The in vivo data were corroborated with the in vitro studies wherein human HCC cells, QGY‐7703 cells, which expressed high levels of AATF, showed reduced AATF expression and decreased levels of TNF‐α and TACE activity upon Marimastat treatment. The gene discussed is ADAM17; the disease is hepatocellular carcinoma.